Author:
Attili Ilaria,Tarantino Paolo,Passaro Antonio,Stati Valeria,Curigliano Giuseppe,de Marinis Filippo
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference108 articles.
1. Pembrolizumab versus chemotherapy for PD-L1-Positive non-small-Cell lung Cancer;Reck;N. Engl. J. Med.,2016
2. Atezolizumab for first-line treatment of PD-L1–Selected patients with NSCLC;Herbst;N. Engl. J. Med.,2020
3. Pembrolizumab plus chemotherapy in metastatic non-small-Cell lung Cancer;Gandhi;N. Engl. J. Med.,2018
4. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial;Mok;Lancet,2019
5. Pembrolizumab plus chemotherapy for squamous non-small-Cell lung Cancer;Paz-Ares;N. Engl. J. Med.,2018
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献